Aclaris Therapeutics, Inc. (ACRS)
5.38
+0.12
(+2.28%)
USD |
NASDAQ |
Sep 24, 16:00
5.25
-0.13
(-2.42%)
After-Hours: 05:47
Aclaris Therapeutics Gross Profit (Annual) : 0.542M for Dec. 31, 2025
Gross Profit (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 0.542M |
| December 31, 2024 | 3.462M |
| December 31, 2023 | 13.17M |
| December 31, 2022 | 17.79M |
| December 31, 2021 | 2.048M |
| December 31, 2020 | 1.349M |
| December 31, 2019 | 0.172M |
| Date | Value |
|---|---|
| December 31, 2018 | 1.822M |
| December 31, 2017 | 0.476M |
| December 31, 2016 | -0.12M |
| December 31, 2015 | -0.09M |
| December 31, 2014 | -0.012M |
| December 31, 2013 | -0.011M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Corcept Therapeutics, Inc. | 748.43M |
| Nektar Therapeutics | 54.21M |
| Xeris Biopharma Holdings, Inc. | 238.43M |
| Alumis, Inc. | 20.55M |
| ANI Pharmaceuticals, Inc. | 450.64M |